Ultrasound Therapy in Georgia

FUSMobile, INC manufactures the Neurolyser XR, a non-invasive therapeutic ultrasound system designed to treat chronic low back pain associated with facet arthritis and vertebral facet joint dysfunction. The Neurolyser XR platform delivers fluoroscopy-guided, focused ultrasound ablative therapy without surgical intervention. The company positions its technology as providing pain relief outcomes comparable to or exceeding invasive standard-of-care procedures while reducing procedure time, complexity, and adverse events. The system is designed for use in clinical settings to address chronic pain management with emphasis on faster patient recovery, reduced healthcare costs, and improved overall patient experience. Target markets include pain management clinics, orthopedic practices, and healthcare systems seeking non-invasive alternatives to surgical interventions for facet-mediated low back pain.

ELvation Medical LLC is the exclusive US sales and distribution partner for the PiezoWave2T MyACT acoustic compression therapy system, manufactured by Richard Wolf Medical Instruments. The company specializes in Acoustic Compression Therapy (MyACT), a modality using focused sound waves to target tissue at varying depths, delivering mechanical stimulus for temporary relief of minor muscle aches and pains. MyACT therapy is intended to increase circulation, improve range of motion, and provide minor pain relief through deep tissue compression and manipulation. The PiezoWave2T MyACT device is assembled in Richard Wolf's Chicago, IL facility and distributed nationwide through a network of licensed practitioners including chiropractors, sports medicine professionals, and rehabilitation specialists. ELvation Medical has held the exclusive distribution agreement since January 1, 2014, and maintains comprehensive provider networks and patient care coordination through its MyACT Connect platform. The company emphasizes treatment efficacy, ease of use, patient adherence, cost-effectiveness, and research support. The PiezoWave2T MyACT is cleared for use in the United States and is intended for acoustic compression therapy applications in addressing minor aches and pains in accordance with FDA-cleared labeling and user manual guidelines.

Shockwave Centers of America is the leading provider of radial shockwave therapy devices designed specifically for chiropractors, physical therapists, and athletic trainers. The company manufactures and distributes advanced shockwave therapy units containing 46 pre-programmed treatment protocols for chronic pain management. Treatments address conditions including plantar fasciitis, frozen shoulder, rotator cuff injuries, knee pain, tennis elbow, golfer's elbow, back pain, Achilles tendinitis, carpal tunnel syndrome, heel spurs, shin splints, calcific tendonitis, hamstring injuries, bursitis, and myofascial trigger points. Each unit delivers ballistic wave therapy in 4–8 minute sessions, typically requiring only one application per week. The company provides comprehensive support including online video training, marketing programs, customer support, and warranty coverage to practitioners.

Compression Therapy Systems LLC is an FDA-registered importer and B2B medical device distributor serving healthcare providers across the US, Canada, Mexico, and the Caribbean since 2012. The company specializes in advanced compression therapy solutions including cold/heat compression therapy units with adjustable temperature control and active compression for post-surgical recovery and orthopedic rehab. CTS supplies top-quality lymphedema and arterial compression therapy systems with multi-chamber garments for clinic and home use, DVT prevention therapy devices (IPC/SIPC/SCD systems) for perioperative and at-risk patients, and pneumatic operating room tourniquet systems for bloodless surgical fields. Additional offerings include the CryoIQ portable cryosurgery device using spray-freezing technology for skin lesion removal, PPE supplies (surgical gloves, masks, face shields), patient monitoring aids (blood pressure cuffs, pulse oximeters, thermometers), mobility aids, and customized sourcing solutions with private-label options. The company emphasizes personalized service, favorable pricing, and flexible rental solutions for healthcare procurement.

SoftWave TRT is a biomedical device manufacturer specializing in FDA-cleared electrohydraulic shockwave therapy systems for tissue regeneration, pain relief, and healing. Founded in 2004 and headquartered in Kennesaw, Georgia, the company has developed over 30 patents for its proprietary SoftWave® technology, which uses spark-initiated acoustic shockwaves to activate cellular healing responses including stem cell activation and improved blood flow without microtrauma. The flagship OrthoGold device and SoftWave Gold Li-Series platform are designed for orthopedic conditions, musculoskeletal pain, chronic diabetic foot ulcers, acute and chronic wounds, burns, and urological/pelvic health applications. The broad-focused, parallel-dispersion shockwave technology delivers results in 10–15 minute sessions with no downtime, and is deployed across leading medical institutions, university hospitals (Mayo Clinic, UCSF, UPMC), and professional sports organizations (MLB, NFL, NBA, NHL, MLS, NCAA, PGA, UFC). SoftWave TRT serves clinicians in sports medicine, orthopedics, wound care, physical therapy, chiropractic, dermatology, and integrative medicine practices.